|
|
Other links at Articles > Pharmacists |
| 1. |
Infliximab for Rheumatoid Arthritis Seen Safe in Japanese Patients
|
|
|
Results of a post-marketing surveillance study in Japan provide a "real world" picture of the incidence of adverse reactions associated with infliximab therapy for rheumatoid arthritis (RA), according to a Japanese research team. They conclude that the safety profile is acceptable. Reuters Health Information
|
| 5. |
Everolimus Effective in Rheumatoid Arthritis Patients
|
|
|
The proliferation signal inhibitor everolimus is effective and safe in rheumatoid arthritis (RA) patients who have an inadequate response to methotrexate, according to trial results reported in the August issue of the Annals of the Rheumatic Diseases. However, development of everolimus for this indication is not being pursued. Reuters Health Information
|
|
|
